TORONTO, ON – March 21, 2025 – Since its establishment in 2018, the Canadian Nuclear Isotope Council (CNIC) has brought Canadian and International organizations from the nuclear, healthcare, and radiopharmaceutical sectors together to expand access, increase production, and explore partnerships
TORONTO, Canada and VIENNA, Austria – March 4, 2025 – This morning, Hua Liu, Deputy Director General and Head of the Department of Technical Cooperation of the International Atomic Energy Agency (IAEA), and James Scongack, Chair of the Canadian Nuclear
TORONTO, ON — February 27, 2025 –The Canadian Nuclear Isotope Council is thrilled to welcome Minogi Corp. as its newest member organization. Minogi is an economic development corporation wholly owned by Mississaugas of Scugog Island First Nation (MSIFN) and based
TORONTO, ON — January 27, 2025 –The Canadian Nuclear Isotope Council is excited to welcome the Nuclear Industry Association of Türkiye (NIATR) as its newest international member organization. The NIATR acts as the public voice of the nuclear industry in
TORONTO, ON — January 16, 2025 -The Canadian Nuclear Isotope Council is pleased to welcome Siemens Healthineers, an international medical technology company, as its newest member organization. Siemens Healthineers plays a critical role in the Canadian and international nuclear medicine
TORONTO, ON – December 17, 2024 – The Canadian Nuclear Isotope Council (CNIC) has, since its establishment in 2018, aimed to foster innovation within Canada’s isotope sector. This innovation has led Canada’s isotope industry to significant growth in recent years,
TORONTO, ON – December 4, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce that Projects Pivot, an Ontario-based project management company, has joined as its newest member organization. Projects Pivot was founded in 2016 by Barbara
TORONTO, ON – November 19, 2024 – The Canadian Nuclear Isotope Council (CNIC) is excited to announce that CUP Contract Labs, a German company offering contract laboratory services to clients across the radiopharmaceutical sector, has joined the CNIC as its
TORONTO, ON – November 15, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Telix Pharmaceuticals, an international biopharmaceutical company, as its newest member organization. Telix Pharmaceuticals (“Telix”) is a commercial-stage biotechnology company producing therapeutic and diagnostic
TORONTO, ON – November 12, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce that SAGE Engineering Services Ltd. has joined its growing network of leading Canadian supply chain companies. SAGE, an engineering firm established in 2000,
Toronto, Ontario – October 23, 2024 – Yesterday, the Government of Ontario released Ontario’s Affordable Energy Future: The Pressing Case for More Power, which details the province’s rising energy demands and the government’s path to proactively managing this demand. The report
TORONTO, ON — Following months of advocacy from the Canadian Nuclear Isotope Council (CNIC) and its industry partners, the Government of Ontario formally recognized the province’s leadership in the global nuclear isotope sector in today’s Phase 2 update to the